MMP9 and neoplasm: Sufficient evidence has revealed that the interaction of CyPA and CD147 could trigger a wide array of diseases and pathological processes, including tumor invasion, inflammation, tissue remodeling, and neural dysfunction, by inducing the expression of matrix metalloproteinase 9 (MMP-9) and activating the NF-κB pathway [18–20].